Global Telemedicine Market Research Report Insight and Industry Analysis By Service Type (Telenursing), Component (Software, Hardware), Deployment (Cloud-Based, On-Premises), Application (Cardiology, Radiology, Dermatology) End Users (Hospitals, Clinics) – Global Forecast Till 2023
Telemedicine Market – Overview The demand for remote clinical services has increased substantially and is motivating the development of the telemedicine market. Reports that gauge the healthcare industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is set to attain a CAGR of 16.8% while reaching expenses worth USD 56,738.3 by the conclusion of the forecast period. The need for better interaction between healthcare providers and patients is one of the main factors motivating the development of the telemedicine market. The mounting implementation of the electronic health record and electronic medical record is projected to spur the progress of the telemedicine market in the upcoming period. Telemedicine Market Segmental Analysis The segmentation of the telemedicine market is carried out on the basis of component, application, service type, deployment, region and end-user. Based on service type, the telemedicine market has been segmented into telepharmacy, teleoncology, telenursing, teleradiology, teledermatology among others. Based on the component, the telemedicine market is segmented into hardware and software. The software-based segment is sub-segmented into integrated software and standalone software. The hardware segment is sub-segmented into medical peripheral devices and monitors. The segmentation of the telemedicine market by deployment comprises of on-premises and cloud-based. On the basis of the application, the telemedicine market is segmented into ophthalmology, cardiology, psychiatry, dermatology, radiology, and others. Based on the end-user, the telemedicine market is segmented into clinics, hospitals and home care. By region, the telemedicine market is segmented into Europe, Asia Pacific, the Middle East, Africa, and the Americas. Telemedicine Market Detailed Regional Analysis The regional assessment of the telemedicine market observes that the Americas region dominates the telemedicine market owing to the incidence of a well-developed healthcare sector, mounting adoption of healthcare IT. Furthermore, increasing healthcare spending and the presence of major players within the region boost market growth. The European region stands next in the telemedicine market due to the mounting implementation of novel technologies in the healthcare sector and escalating government support to deal with healthcare demands. The Asia Pacific region is anticipated to be the fastest rising region owing to a vast patient pool and rising demand for the telemedicine sector. Furthermore, the incidence of constantly rising economies like Australia, India, and China within the region is expected to stimulate market growth. The Middle East and African region have the smallest share in the telemedicine market owing to the incidence of underprivileged economies, scarcity of healthcare services and strict government policies, particularly within the African region. Telemedicine Market Competitive Analysis The escalated turnaround in the market is likely to set off new openings for the development of the market. The enhancement in different domestic economies is projected to encourage the progress of the market in the impending period. The ease in accessing key planned opportunities important to consequent stabilization of inflation is projected to generate a promising option for development in the approaching years. In the approaching years, the control exerted by fairly high-income level nations around the world and the likely gains observed towards a few of the currencies around the world is projected to strengthen the fruition of the market in the forecast period. A significant climb in the number of backers in the market is expected to craft an advantageous state of affairs for the evolution of the market in the projected period. The advancement of the market is projected to capture amplified impetus in the coming years chiefly due to the incidence of contributory government plans. The eminent competitors in the telemedicine market are CardioNet, CareClix, Cerner Corporation, Cisco, GENERAL ELECTRIC, AMD Global Telemedicine, Inc., IBM Corporation, Intel Corporation, Koninklijke Philips N.V., Medtronic, SHL Telemedicine, TeleVital, Iris Telehealth, Aerotel Medical Systems, Allscripts Healthcare Solutions, Cardiocom, Honeywell Lifesciences, Care Innovations, Medvivo Group Ltd., Tunstall Healthcare, Aerotel Medical Systems Ltd., and others. get full report @https://www.marketresearchfuture.com/reports/telemedicine-market-2216 Browse other healthcare related report Sex Cord Gonadal Stromal Tumor Market Endometrial Cancer Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
0 Comments
Global Infertility Market Information; By Sex (Males, Females And Unexplained), By Diagnosis (Men Diagnostic Tests (Semen Analysis, Genetic Testing, Testicular Biopsy) And Women Diagnostic Tests (Hysteroscopy, Laparoscopy, Ovulation Testing, Hysterosalpingography)) And General Diagnostic Tests (Genetic Testing, Hormone Testing, Microscopic Analysis, Imaging), By Drugs (Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment), By Techniques (Assisted Reproductive Technology (Art), Intrauterine Insemination, And Surgery (Laparoscopic Or Hysteroscopic Surgery, Tubal Surgeries)) – Forecast To 2023
Infertility is a medical condition in which male or female members are unable to reproduce or have children. Common conditions for the condition include low sperm motility, genetic deficiencies, and psychological issues. According to the Centers for Disease Control & Prevention (CDC), close to 6% unmarried women are unable to attain pregnancy even after unprotected intercourse. The global infertility market report compiled by Market Research Future (MRFR) contains pertinent factors and challenges of customers as well as efforts of industry stalwarts in easing the process of reproduction. Infertility Market Outlook Global infertility market is estimated to accrue significant revenue by exhibiting a CAGR of 4.6% during the forecast period (2017-2023). It stood at USD 11.2 billion in 2016. Major growth drivers of the market include late marriages, sedentary lifestyles, genetic deficiencies, environmental factors, and health history. Awareness of the condition and preventive measures in terms of treatment is likely to drive the market growth. Emergence of various clinics which can conduct tests discreetly can bode well for the market. In addition, the recognition of infertility as a disease by insurance organizations and coverage packages being dispensed to patients is a sign of the large potential of the market. Technological advances in terms of artificial reproduction technique (ART) and artificial insemination are predicted to bolster the global infertility market growth. Successful outcomes of such methods, as well as conduction of clinical trials for safe methods of conception among couples, are other major drivers of the market. High treatment costs, side effects of infertility treatment, and societal taboos are factors which can impede market growth. Infertility Market Segmentation Analysis The global infertility market report is segmented by sex, diagnosis, drugs, and techniques. By sex, it is segmented into male, female, and unexplained. By diagnosis, it is segmented into men diagnostic tests, female diagnostic tests, and general diagnostic tests. Testicular biopsy, genetic testing, semen analysis, and others are major sub-segments within the men diagnostic tests segment. Female diagnostic tests, on the other hand, is segmented into hysterosalpinogography, hysteroscopy, laparoscopy, ovulation testing, and others. Microscopic analysis, imaging, hormone testing, genetic testing, and others are segments within general diagnostic tests. By drugs, it is segmented into serophene, clomiphene citrate, letrozole, hormone treatment, and others. By techniques, it is segmented into assisted reproductive technology (ART), surgery, and intrauterine insemination. Surgery is further segmented into tubal surgeries, laparoscopic or hysteroscopic surgery, and others. Infertility Market Regional Analysis North America, Asia Pacific, Europe, and the Middle East & Africa (MEA) are the regions being considered for the basis of the report. North America is predicted to dominate the market led by the U.S. Factors facilitating regional market growth include rise in awareness levels of patients, high expendable income levels of patients, and reimbursement schemes. Infertility Market Competitive Outlook SCSA Diagnostics, Inc., Bayer Healthcare, EMD Serono, Inc., Zydus Cadila Healthcare Ltd, Aetna Inc., Androvia LifeSciences, Andrology Solutions, Halotech DNA, and others are prominent names within the global infertility market. Infertility Industry News Seed funding to accelerate research and development efforts put into fertility treatments is expected to increase due to successful outcomes as well as demand for affordable treatment methods. Recently, Mojo is planning to raise USD 1.8 million in capital with the help of Nordic firm, Inventure. The firm plans to use robotics and artificial intelligence to assist in egg and sperm quality analysis as well as develop methods to lower fertilization costs. Get More Information on Infertility Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/infertility-market-6145 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Epigenetics is the analysis and study of heritable changes in gene function not involving changes in the DNA sequence such as changes in a chromosome, phenotypic affecting gene activity, and expression.
The global epigenetics market is valued at USD 800 million in 2016 and is expected to expand at a 12.9 % CAGR during the study period of 2016 to 2023. Market Dynamics: Oncology Segment Is Expected To Be The Largest Driver Of Market Growth The growing incidence of cancer is the prime drivers of the market. According to W.H.O. cancer was responsible for 8.8 million deaths in 2015, indenting nearly 1 in 6 patient’s deaths. Common carcinomas are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer, recording 1.69 million, 788,000, 774 thousand, 754 thousand, and 571 thousand deaths respectively in the year 2015. According to the estimates of the Centers for Disease Control and Prevention, almost 1.5 million people are diagnosed with cancer per year in the U.S. alone, resulting in more than five lakh deaths. Technology Development Is Expected To Drive A Faster Market Adoption The development of highly sensitive and selective tests, instrumentation and a concurrent rise in computational power is driving a broad adoption. The advancements such as the development of DNA and RNA modifying enzymes such as acetylases, methyltransferases, reverse transcriptase, ligases, and other protein-modifying enzymes has generated tremendous enthusiasm and concurrent faster market adoption. The growing government support for biotechnology and growing partnership between academia and industry is another driver of growth. Attractive and critical advantages of technology exemplified by high-throughput molecular analysis of tissues, such as quick, cost-effective, efficient for less labor intensive and requires a lesser number of steps are the operational and economic driving factors of the market. Other technological developments include automation, advances in PCR technology, strategic and cross-functional nature of the molecular diagnostic technology and others. High Cost Of Installation And Maintenance And Nascent Stage Of Technology May Hamper The Market Growth The prime market constraints include prohibitive costs of molecular diagnostics, the high cost of manufacturing, consolidated nature of the market has put a premium on the price of the epigenetics products, nascent stage of technology and high power of firms relative to buyers. Segments: To generate a bird’s view of the global epigenetics market, the report is segmented based on instruments, consumables, applications, technology, end users, and regions. Based on instruments, the market comprises of NGS, spectrometer, PCR, software solutions and others. Based on consumables, the market comprises of kit, enzymes, reagent, and others. Based on application, the market comprises of oncology, developmental biology, drug discovery, cardiology, immunology, and others. Based on technology, the market comprises of methylation, histone modification, and others. Based on end users the market is segmented into academia and research, pharmaceutical and biotechnology industry and others. Based on the regions, the market is segmented as North America, Europe, Asia Pacific Middle East and Africa and rest of the world. Regional analysis: North America led by the U.S. accounts for the most significant market share of the market, owing to faster technology uptake, the large biotech sector of the U.S., the presence of large advanced players, growing prevalence of cancer. Europe led by Germany, U.K., and France accounts for the second-largest and second fastest market during the forecasted period. Asia led by Japan and supported by China, South Korea, and India is anticipated to be the fastest growing market. The Middle East and Africa market will expand at a slower rate on account of the weak industry landscape and low demand due to weak economic conditions. Key Vendors: Some of the dominant vendors operating in the report are Bio-Rad (US), Illumina (US), QIAGEN (Netherlands), Thermo Fisher (US), Active Motif (US), Diagenode (Belgium), Agilent (US), Merck Millipore (US), Abcam (UK), New England Biolabs (US), PerkinElmer (US), Zymo Research (US), and others. Access Report @ https://www.marketresearchfuture.com/upcoming-reports/epigenetics-market-6161 Intended Audience
Sex Cord Gonadal Stromal Tumor Market Bariatric Surgery Devices Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Needle Free Injection Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.
Industry Report “Needle Free Injection Market Research Report – Forecast to 2023” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement Needle Free Injection Market Overview The global Needle Free Injection Market size is expected to touch USD 25,057.4 million by 2023 owing to high prevalence of diabetes and chronic diseases. Market Research Future’s (MRFR) latest study reveals that the market is predicted a 15.28 % CAGR during the forecast period (2018–2023). Needle free injections are medical devices which deliver drugs directly via the skin instead of using hypodermic needles as a medium. High demand for needle free injectors in home healthcare in North America and Europe is expected to augur market growth. In addition, rising investments in biopharmaceuticals are expected to provide the market a much-needed impetus. Regional Outlook The needle free injection market, on the basis of region, is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The Americas are expected to dominate the global market owing to prevalence of chronic diseases and demand for self-administrative devices. Technological breakthroughs in pharmaceutical and biotechnology sectors, investments by industry participants, and high awareness among patients are factors anticipated to fuel market growth over the forecast period. Europe is expected to register a significant growth rate over the forecast period due to the presence of well-established healthcare infrastructure and huge patient pool. The APAC needle free injection market is projected to showcase a robust CAGR over the forecast period owing to strong economies of India and China. Increased healthcare expenditures of these developing economies coupled with a large patient pool can spur market demand. Enhanced safety and quality standards adhered by manufacturers of these medical devices can culminate in remarkable product sales. Get Detailed Information on Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) – Forecast Till 2023 @ https://www.marketresearchfuture.com/reports/needle-free-injection-market-6180 Leading Market Players CROSSJECT, Medical International Technology, Inc., National Medical Products Inc., INJEX Pharma GmBH, PenJet Corporation, Valeritas Holdings, Inc., Antares Pharma Inc., D'Antonio Consultants International, Inc., MIKA MEDICAL CO., PharmaJet, Inc., Endo Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., and European Pharma Group are prominent players in the needle free injection market. Related News Telemedicine Market Infection Control Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. https://www.marketresearchfuture.com/ Market Research Future published a research report on I Endometrial Cancer Market Research Report – Forecast to 2023.Report gives a clear picture of current market scenario which includes past and estimated future market size
Endometrial Cancer Market Overview The global Endometrial Cancer Market is expecting a robust CAGR and a strong market presence during the forecast period (2018-2023), in an all-inclusive study asserts Market Research Future (MRFR). Endometrial cancer is also known as uterine cancer and is the sixth most common cancer in women across the world. The daunting number speaks for itself and promotes the factors that ensure the market growth for endometrial cancer. Drivers and Restraints: Urbanization across the world is experiencing an express speed growth rate owing to which the population is undergoing remarkable lifestyle change. A sedentary lifestyle has become the norm for many, and growing obesity among women is resulting in the rising number of endometrial cancer. Lack of nutritional elements in consumed food and other diseases such as polycystic ovarian syndrome (PCOS) and the ovarian tumor can trigger endometrial cancer. Segmentation: The global endometrial cancer market can be segmented by diagnosis, treatment, and end-user. By diagnosis, the market can further be segmented into the pelvic examination, transvaginal ultrasound, endometrial biopsy, dilation and curettage (D&C), and laparoscopy. Endometrial biopsy is very common as the confirmatory test for uterine cancer. Treatment-based market includes hysterectomy techniques, radiation, hormone therapy, chemotherapy, and palliative care. The hysterectomy techniques category comprises open abdominal hysterectomy, total vaginal hysterectomy, total laparoscopic hysterectomy, and robotic hysterectomy. External radiation and internal radiation (brachytherapy) are part of radiation technology. The hormonal therapy consists progestins, tamoxifen, luteinizing hormone-releasing hormone agonists, and aromatase inhibitors. Chemotherapy can be further sub-segmented into paclitaxel, carboplatin, doxorubicin, and cisplatin and is also the most-used treatment method. Get Global Endometrial Cancer Market Research Report, by Diagnosis (Pelvic Examination, Transvaginal Ultrasound, Endometrial Biopsy), Treatment (Hysterectomy, Radiation), End-User (Hospitals & Clinics, Ambulatory Surgical Centers) – Global Forecast Till 2023 @ https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226 Market Dashboard: The prominent players involved in the market are Pfizer Inc., General Electric Company, Koninklijke Philips N.V., LUPIN, PHYTON, Bayer AG, Celgene Corporation, Johnson & Johnson, CooperSurgical Inc., LiNA Medical USA, Conceptus Inc., Hologic Inc., Karl Storz GmbH & Co. Kg, and Boston Scientific Corporation. Related Healthcare News Telemedicine Market Infection Control Market About Market Research Future: MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions Contact: www.marketresearchfuture.com Global Sterilization Equipment Market 2019 Size, Overview, Analysis, Key Methodologies, Top Players Success Milestones and Forecasts to 2023
Sterilization Equipment Market Size By Product (Heat Sterilization, Low-Temperature Sterilization, and Others), By Technology (Gravity, Vacuum, Steam, Forced Convention), and By End-User (Pharmaceutical Companies and Others) Market Leading Players Apart from Boekel Scientific, the other key players ruling the market include 3M, Advanced Sterilization Products (Division of Ethicon), Getinge AB, Anderson Products, Technologies Kft., Cantel Medical., Merck & Co., LTE Scientific, Inc, MMM Group, STERIS plc., Celitron Medical, Midmark Corporation, SAKURA SI CO., LTD., Fedegari Autoclavi S.p.A., TSO3 INC., Belimed, and Sotera Health. The Expanding Global Geriatric Population is Likely to Influence the Growth of the S S Sterilization Equipment Market Positively Market Overview Sterilization equipment are essential to uphold the sterile conditions throughout making of pharmaceuticals, during medicinal procedures, and research activities. The growing elderly population, an increasing number of surgical activities and growing research and development activities in the healthcare industry are the key factors propelling the growth of the worldwide sterilization equipment market. Furthermore, soaring R&D outlay and aggressive tactics adopted by the top players, such as novel product launches, are contributing to the development of the market. For example, Cantel Medical announced in August 2018, the acquisition of Stericycle's Controlled Environmental Solutions Business for USD 17 million. It is a key provider of certification and testing, decontamination services for clean rooms, environmental monitoring, and other services associated with quality control and regulatory compliance. Market Segmentation Based on product, the market has been segmented as low-temperature sterilization, heat sterilization, ionizing radiation sterilization, and filtration sterilization. The heat sterilization segment has been sub-segmented into moist heat sterilization and dry heat sterilization. The low-temperature sterilization segment has been sub-segmented into hydrogen peroxide sterilization, ethylene oxide sterilization, and others. The ionizing radiation sterilization segment has been sub-segmented as gamma rays and electron beams. The technology segment has been segmented into forced convention, steam, natural convection gravity, and vacuum. On the basis of end–user, worldwide sterilization equipment market has been segmented into research institutes, hospitals & clinics, medical device companies, food & beverage industry, pharmaceutical companies, and other end–users. Get full report @ https://www.marketresearchfuture.com/reports/sterilization-equipment-market-6397 Key Questions Answered in This Report
Browse other healthcare related report Sex Cord Gonadal Stromal Tumor Market Endometrial Cancer Market About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: https://www.marketresearchfuture.com Market Research Future published a research report on Flow Cytometry Market Research Report – Forecast to 2023.Report gives a clear picture of current market scenario which includes past and estimated future market size Flow Cytometry Market Size Overview Flow cytometry is a technique used to identify the characteristics of a cell or a particle using a laser beam. Flow cytometry is used in various research and development activities and it also has applications in medical diagnostics. The growing adoption of new technology, increasing use of flow cytometry in diagnostics, and increasing applications of flow cytometry in pharmaceutical research and development are the major factors driving the growth of the global Flow Cytometry Market Size Leading Manufacturers Beckman Coulter, Inc., Becton, Dickinson and Company., Danaher., Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex Partec GmbH Agilent Technologies, Inc., Sony Corporation, Biomérieux S.A., and Enzo Biochem Inc. Regional Analysis The market in the Americas is expected to dominate the global flow cytometry market during the forecast period owing to the technological advancement, increasing prevalence of autoimmune diseases, and well-established healthcare sector in the region. The European market is expected to be the second-largest due to the increasing number of cancer patients in the region and government funding and support of the healthcare sector. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to increasing awareness about healthcare, increasing research and development activities and favorable government initiatives for the establishment of healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global flow cytometry market. Intended Audience Flow cytometry equipment and reagent manufacturers Flow cytometry equipment distributors and suppliers Healthcare providers Medical device manufacturers Research institutes and academic centers Contract research organizations (CROs) Government associations Market research and consulting GET DETAILED INFORMATION OF Global Flow Cytometry Market Information by Product & service (Reagents and Consumables), Technology (Cell-Based Flow Cytometry), Application (Research Applications and Immunology), End-User (Research Institutes, Commercial) –Global Forecast Till 2023@ https://www.marketresearchfuture.com/reports/flow-cytometry-market-6433 Browse other healthcare related report Sterilization Equipment Market Endometrial Cancer Market About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: https://www.marketresearchfuture.com Mucormycosis (zygomycosis) is a serious but rare fungal infection caused by a group of molds called mucormycetes. Moreover, inhaling fungal spores from the air can affect the lungs and sinuses, the fungus also invades the skin through wounds such as cut, scrape, burn, or other type of skin trauma. There are approximately 1.5 million different species of fungi on the earth, however, only around 300 are responsible for causing diseases and infections in humans. Fungal infection may affect anyone, but they are most common in people with weakened immune systems and can occur in nearly any part of the body. Risk factors for developing mucormycosis include uncontrolled diabetes, cancer, organ transplant, neutropenia, skin trauma such as cuts, scrapes, punctures, or burns.
These infections need to be treated with prescribed antifungal medication, usually amphotericin B, posaconazole or isavuconazole. Amphotericin B, posaconazole, and isavuconazole are medications given intravenously. Furthermore, posaconazole and isavuconazole can also be administered orally. Often, mucormycosis requires surgery to remove the infected tissue. The prognosis of mucormycosis is usually poor. It depends on various factors such as the overall health of the patient and ability to respond to treatments, the speed of diagnosis, and treatment provided. For instance, the mortality rate with rhinocerebral and GI mucormycosis is about 85% while the mortality rate for patients with other types of mucormycosis is about 50%. Patients who survive this infection often end up having disabilities such as blindness, limb loss, organ dysfunctions among others. Mucormycosis Market growth is mainly driven by the increasing prevalence of fungal infections, availability of a wide range of products, and rising incidence of immunological diseases. Moreover, increasing awareness about fungal infection and increasing government support for research & development have fuelled the market growth. However, side effects of the treatment and presence of misbranded and spurious drugs may slow the growth of the market. There are a number of medicines available in the market for the treatment of fungal infections such as oral and intravenous medicines, creams, sprays, shampoos, solutions, and pessaries. Rising incidence of immunological diseases and availability of a wide range of products has driven the growth of the global mucormycosis market. Furthermore, the rising geriatric population, increasing government support, and increasing healthcare expenditure have fueled the growth of the market. However, side effects of the drugs and the presence of misbranded drugs may hinder the growth of the market. The global market for mucormycosis is expected to grow at a CAGR of approximately 7.3% during the forecast period, 2017-2023. Segmentation: The mucormycosis is segmented on the basis of species, diagnosis, treatment, and end-users. On the basis of the species, the market is segmented into Rhizopus, Rhizomucor, Cunninghamella, Apophysomyces, Saksenaea, Lichtheimia (formerly Absidia), and Mucor, and others On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), tissue biopsy, and others. On the basis of the treatment, the market is segmented into surgery, antifungal drugs, amphotericin B therapy, and others. The antifungal drugs is further categorized into posaconazole, isavuconazole, voriconazole, fluconazole, and flucytosine, and others. On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others. Regional Analysis: The global mucormycosis market consists of countries namely the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas dominate the global mucormycosis market owing to a well-developed healthcare sector and huge patient population for mucormycosis. Many antifungal drugs have lost their patients during the last few years such as Terbinafine products like Lamisil lost their patient in 2017. As there is limited oral preparation in the market, development and licensing of new drugs in the market is the huge opportunity for the development of the market during the forecasted period. Europe is the second largest market for the global mucormycosis owing to the advancements in the technology of the surgical devices along with the rising occurrence of fungal infections among the patients. The European government introduced incentives to help simplify the improvement of anti-infective drugs and dropping the risk and cost of manufacturers. Some other factors driving the market include the growing percentage of diabetes mellitus population mainly in the developed countries of Europe. The average diabetes prevalence rate in Europe is 8.6% of the adult population. Asia Pacific is the fastest growing region for antifungal treatment due to increasing prevalence of HIV, and huge untapped growth opportunities for the development of the market. Every year, approximately 7.1% of the Korean population receives treatment for fungal diseases. Therefore, further research is needed to understand and monitor the prevalence of mycoses to establish management policies to reduce the burden of fungal diseases. While the Middle East & Africa had the lowest share in antifungal treatment market, in 2016. Key Players: Some of key the players in the global mucormycosis market are Abbott Laboratories (U.S.), Biocon Limited (India), Cadila Pharmaceuticals Limited (India), Novartis AG (Switerzland), F. Hoffman La Roche (Switerzland), Merck Sharp and Dohme (U.S.), Mylan Labs (U.S.), Bristol Myers Squibb (U.S.), Bayer AG (Germany), Lonza Group (Switerzland), Sanofi (France), Johnson & Johnson (U.S.), Pfizer Inc. (U.S.), Gilead Sciences (U.S.), and others Browse More Details @https://www.marketresearchfuture.com/reports/mucormycosis-market-5440 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |